# ELTROMBOPAG OLAMINE
> **ANDA220660** · Abbreviated New Drug Application (Generic) · Sponsor: AIZANT · Approved 2026-04-28
## Drug
- **FDA Application Number:** ANDA220660
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ELTROMBOPAG OLAMINE
- **Generic name:** Eltrombopag Olamine
- **Active ingredients:** ELTROMBOPAG OLAMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AIZANT
- **First approval:** 2026-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220660)
---
*MORVS · CC0 1.0*